Skip to main content
Caplight Logo









Creo

Creo

Private
San Diego, CaliforniaHealthcare & Life Scienceshttps://creoingredients.com/

Last Round

VC Round

Sep 29, 2020

Company Overview

Creo is a biotechnology company that produces rare and novel cannabinoid ingredients using a proprietary fermentation-based platform.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Fashion & Beauty, Sustainable Materials

Business Model

B2B

Customer Profile

Services & Consulting

AI Layer

Non-AI

Keywords

cannabinoid ingredientsfermentation technologyCBGCBGAsynthetic biologylab-grown cannabinoidsbiotechnologyclean manufacturingsustainable ingredientsB2B ingredient supplierbioprocessingCPG ingredientsplant-free alternativesnovel cannabinoids

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Creo Comparables

Compare Creo with similar companies based on industry and business-model similarity.

Creo comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Biomedican
89%
Demetrix
85%
Lygos
85%

Creo Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
VC RoundSep 29, 2020

Key People

Founding team and executive leadership

Roy Lipski

CEO and Co-founder

Founding Team

Market signals

Structured signals derived from secondary market and firmographic data.

  • Sep 29, 2020

    $50M raised in a VC Round.

Creo Filings

Explore SEC and related filing metadata, where available.

Creo filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Creo's valuation, stock price, and market status.

Is Creo a public or private company?

Creo is a private company.

What is the current stock price of Creo?

Creo is a private company with no public stock price. No recent secondary market data is available.

How much is Creo worth (valuation)?

Valuation information for Creo is not publicly available.

Can I buy Creo stock?

Creo shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Creo's last funding round?

Creo's most recent funding round was VC Round on September 29, 2020.

Who are the main investors in Creo?

Investor information for Creo is not publicly disclosed.

Will Creo IPO soon?

No public IPO plans have been announced for Creo.

How can I track Creo secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Creo's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersSan Diego, California
Employee Range9
Year Founded2016
Last FundingSep 29, 2020

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?